Updated Monday, 11/9.
The US IPO market remains relatively quiet following election week, with three biotechs and one SPAC scheduled to raise $340 million in the week ahead.
Oncology biotech IN8bio (INAB) plans to raise $75...read more
Nine IPOs and five SPACs went public this past week, and one IPO postponed. New filing activity continued to pump the breaks as we near the election, with just one new IPO filing. SPAC activity continued unabated however as nine submitted initial filings. ...read more
Codiak BioSciences, an early stage biotech developing novel exosome therapeutics for cancers, raised $83 million by offering 5.5 million shares at $15, the midpoint of the $14 to $16 range. Codiak BioSciences plans to list on the Nasdaq under the...read more
Five biotechs, two medical device makers, a solar panel mounting manufacturer, and a Chinese retailer are scheduled to raise $2.0 billion in the week ahead. Several companies could join the IPO calendar early in the week, including leading cybersecurity...read more
US IPO Week Ahead: Biotechs break the post-election ice in a 3 IPO week
Updated Monday, 11/9. The US IPO market remains relatively quiet following election week, with three biotechs and one SPAC scheduled to raise $340 million in the week ahead. Oncology biotech IN8bio (INAB) plans to raise $75...read more
US IPO Weekly Recap: Solar technology shines in a 9 IPO week
Nine IPOs and five SPACs went public this past week, and one IPO postponed. New filing activity continued to pump the breaks as we near the election, with just one new IPO filing. SPAC activity continued unabated however as nine submitted initial filings. ...read more
Cancer biotech Codiak BioSciences prices IPO at $15 midpoint
Codiak BioSciences, an early stage biotech developing novel exosome therapeutics for cancers, raised $83 million by offering 5.5 million shares at $15, the midpoint of the $14 to $16 range. Codiak BioSciences plans to list on the Nasdaq under the...read more
US IPO Week Ahead: Healthcare, solar panels, and Chinese retail in a 9 IPO week
Five biotechs, two medical device makers, a solar panel mounting manufacturer, and a Chinese retailer are scheduled to raise $2.0 billion in the week ahead. Several companies could join the IPO calendar early in the week, including leading cybersecurity...read more